Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NORDIC BIOSCIENCE CLINICAL STUDIES A/S
A/S
In liquidation
Advertising protection
CVR 21144347
Herlev Hovedgade 207, 2730
Herlev
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 1998 · 28 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
NORDIC BIOSCIENCE CLINICAL STUDIES A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-2M
2012
0M
2013
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
-2M
2012
0M
+100%
2013
Income statement
DKK thousands
Item
2012
2013
Gross profit
-2.276
53
Staff expenses
-0
-0
EBITDA
-2.217
271
Depreciation & amort.
-0
-0
EBIT
-2.217
271
Net financials
287
-1.870
Profit before tax
-1.931
-1.599
Tax
965
491
Net profit
-2.896
-2.089
Balance sheet
DKK thousands
Item
2012
2013
Total assets
3.234
1.498
Equity
1.441
-648
Long-term debt
0
0
Short-term debt
1.793
2.146
Total debt
1.793
2.146
Financial ratios
5-year trend
EBITDA margin (of gross profit)
512.7%
This company
2012
2013
Equity ratio
-43.3%
This company
38.2%
Market median
-213% vs market
2012
2013
Return on equity
-208931500.0%
This company
18.4%
Market median
-1135497383% vs market
2012
2013
Net profit margin (of gross profit)
-3949.4%
This company
2012
2013
Asset turnover (of gross profit)
0.04×
This company
2012
2013
Debt / equity
3.31×
This company
0.62×
Market median
-434% vs market
2012
2013
Annual reports & filings
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on NORDIC BIOSCIENCE CLINICAL STUDIES A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
